Journal of Environmental Biology
Journal of Environmental Biology
Journal of Environmental Biology
Number 5
September 2024
®
Journal of Environmental Biology
p-ISSN: 0254-8704 • e-ISSN: 2394-0379 • CODEN: JEBIDP
The Editorial Board members of Journal of Environmental Biology comprises qualified academicians from institutions
worldwide. They assist in scholarly publication of research papers in Journal of Environmental Biology.
It is hoped that the journal will achieve greater scientific excellence with their cooperation and expertise.
Editor
Dr. Sumati Gaumat, Ph. D., Journal of Environmental Biology, Lucknow, India (Botany)
Advisory Editors
Professor S.S.S. Sarma, National Autonomous University of Mexico, Tlalnepantla, Mexico (Limnology and Eco-toxicology)
Dr. Amit Kumar Ghosh (Emeritus Scientist), Birbal Sahni Institute of Palaeosciences, Lucknow, India (Palaeobiology & Past Climatology)
Professor Em. Suresh V.S. Rana, Choudhary Charan Singh University, Meerut, India (Toxicology)
Professor Eric M. Hallerman, Virginia Polytechnic Institute and State University, Virginia, U.S.A. (Genetics & Aquaculture)
Dr. George N. Zaimes, International Hellenic University, Drama, Greece (Watershed and Riparian Areas Management & Soil Conservation)
Associate Editors
Professor Anastasia Pantera, Agricultural University of Athens, Karpenissi, Central Greece (Agroforestry & Forestry)
Professor N.K. Dubey, Banaras Hindu University, Varanasi, India (Bioprospection & Pesticides Toxicology)
Professor Surendra S. Bargali, Kumaun University, Nainital, India (Ecology)
Professor Anand Kar, Devi Ahilya University, Indore, India (Heavy Metal, Pesticide & Drug Toxicity)
Dr. K. Sadasivan Pillai, International Institute of Biotechnology and Toxicology, Padappai, India (Toxicology)
Dr. T.V. Ramachandra, Indian Institute of Science, Bengaluru, India (Aquatic Ecosystem, Biodiversity & Conservation)
Professor Sudip Barat, University of North Bengal, Siliguri, India (Fisheries, Aquaculture, Limnology & Eco-Toxicology)
Dr. A.K. Chakravarthy (Rtd.), Indian Institute of Horticultural Research, Bangalore, India (Entomology & Nematology)
Professor C.P. Srivastava, Banaras Hindu University, Varanasi, India (Agricultural Entomology)
Professor Munir Ozturk (Rtd.), Ege University, Izmir, Turkey (Eco-physicology)
Professor Mohd. Y. A. Shukor, University Putra Malaysia, Selangor, Malaysia (Environmental Biochemistry)
Dr. Qtae Jo, Hanseo University, Chungnam, Republic of Korea (Aquaculture-Environment)
Dr. Sujoy Saha, ICAR- National Research Centre for Grapes, Pune, India (Plant Pathology)
Professor Sanjay-Swami, College of Post Graduate Studies in Agricultural Sciences(CAU), Umiam, India (Natural Resource Management)
Contd......
Journal of Environmental Biology, September 2024
®
Journal of Environmental Biology
p-ISSN: 0254-8704 • e-ISSN: 2394-0379 • CODEN: JEBIDP JEB
Consulting Editors
Dr. Daeui Park, Korea Institute of Toxicology, Daejeon, South Korea (Toxicology)
Professor P. J. John, University of Rajasthan, Jaipur, India (Environmental Toxicology)
Professor Manjulatha Chapara, Andhra University, Visakhapatnam, India (Crustacean Physiology, Aquaculture)
Dr. Gerardo Díaz-Godínez, Autonomous University of Tlaxcala, Tlaxcala, Mexico (Fungal Biotechnology)
Dr. Saurabh Chandra, Dabur Research Foundation, Ghaziabad, India (Zoology & Animal Toxicology)
Dr. K. M. Rajesh, ICAR - Central Marine Fisheries Research Institute, Mangaluru, India (Marin Ecology, Biodiversity & Fish Biology)
Dr. Debajit Sarma, ICAR-Central Institute of Fisheries Education, Versova, India (Aquaculture)
Dr. Dharmendra Kumar Meena, ICAR-Central Inland Fisheries Research Institute, Barrackpore, India (Fisheries Resource Management)
Dr. Tapati Das, Assam University, Silchar, India (Aquatic Ecology & Biodiversity)
Dr. Santosh Kumar Karn, Sardar Bhagwan Singh University, Dehradun, India (Environmental Biotechnology)
Dr. Mukesh K Meghvansi, Defence Research & Development Establishment (DRDO), Gwalior, India (Microbial Biotechnology)
Dr. Karmabeer Jena, Central Tasar Research and Traing Institute (CSB), Ranchi, India (Biochemistry)
Professor Bharat Bhusan Patnaik, Fakir Mohan University, Balasore, India (Molecular Genetics & Genomics)
Professor J. V. J. Silva Júnior, Federal University of Santa Maria, Santa Maria-RS, Brazil (Virology, Immunology & Genetics)
Dr. Pradipta Saha, University of Burdwan, Burdwan, India (Microbiology)
Dr. S. Jayashree, KG College of Arts and Science, Coimbatore, India (Microbiology)
Dr. Om Prakash, National Centre For Cell Science, Pune, India (Microbiology)
Dr. Valasia Iakovoglou, University of Thessaly, Karditsa, Greece (Environmental Education & Forestry)
Dr. Nitin Kulkarni, ICFRE-Tropical Forest Research Institute, Jabalpur, India (Forest Entomology)
Professor José L. García Rodríguez, Polytechnic University of Madrid, Madrid, Spain (Hydraulics and Hydrology and Watershed)
Professor A. Vijaya Anand, Bharathiar University, Coimbatore, India (Phytos-Therapeutics)
Professor Ravindra Khaiwal, PGIMER, Chandigarh, India (Environmental & Occupational Health)
Professor P. S. Chaudhuri, Tripura University, Suryamaninagar, India (Earthworm Biology, Biodiversity & Ecology)
Dr. Afroz Alam, Banasthali Vidyapith, Vanasthali, India (Bryophytes & Environmental Botany)
Professor Avtar Singh Bimbraw, Punjab Agricultural University, Ludhiana, India (Agronomy)
Dr. A. K. Trivedi, ICAR - Central Institute for Subtropical Horticulture, Lucknow, India (Plant Physiology)
Dr. Surendra Pratap Singh, ICAR-Indian Institute of Sugarcane Research, Lucknow, India (Plant Physiology & Abiotic stresses)
Professor Renu Munjal, Chaudhary Charan Singh Haryana Agricultural University, Hisar, India (Plant Physiology & Genetics)
Dr. Mather A. Khan, University of Missouri,Columbia, USA (Molecular Plant Biology & Abiotech stress)
Dr. Rashid Ismael Hag Ibrahim, King Faisal University, Al-Ahsa, Saudi Arabia (Plant Molecular Biology and Genomics)
Dr. P. S. Harikumar, Centre for Water Resources Development and Management, Calicut, India (Environmental Monitoring)
Professor Abd El-Latif Hesham, Beni-Suef University, Beni-Suef, Egypt (Environmental Meta-Genome Biotechnology)
The Research and Development (R&D) Division is a unique feature of the organization. A team of expert scientists in this division keeps
pace with the latest advancements made in different research fields, scrutinise reviewed and edited papers for unethical practices and
technical quality at each stage of publication to enhance the scientific merit of the research papers.
Consultant: Dr. R. B. Raizada, Scientist (Retired), Indian Institute of Toxicology Research, Lucknow - 226 001 (India).
Advisor: Dr. Amit Kumar Ghosh, Emeritus Scientist, Birbal Sahni Institute of Palaeosciences, Lucknow-226 007 (India).
Scientist-in-charge: Dr. Sumati Gaumat, Journal of Environmental Biology, Lucknow - 226 022 (India).
Assistant Scientist: Dr. Purnima Raizada, Journal of Environmental Biology, Lucknow - 226 022 (India).
The following scientists acted as reviewers for the papers published in September issue of the Journal i.e., 45 (5) 2024
besides the Editorial Board Members. Our R&D division scientists further rechecked all the papers before publication.
To all of them, Journal of Environmental Biology thank for their valued services.
Contd......
Journal of Environmental Biology, September 2024
®
Journal of Environmental Biology
p-ISSN: 0254-8704 • e-ISSN: 2394-0379 • CODEN: JEBIDP JEB
Dr. Mahender Singh, Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu, Jammu, India
Dr. Manjunatha Gowda Thondihalu, ICAR- Indian Institute of Vegetable Research, Varanasi, India
Dr. Moovendhan, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India
Dr. Muthukumar. M., ICAR-Central Institute for Subtropical Horticulture, Lucknow, india
Dr. Naseema Rahman, RARS, AAU, Shillongani, Nagaon, India
Dr. Neelavannan. K., Indian Institute of Technology, Kanpur, India
Dr. P. K. Pradhan, ICAR- National Bureau of Fish Genetic Resources, Lucknow, India
Dr. Pankaj Kumar, ICAR-Research Complex for Eastern Region, Patna, India
Dr. Prem Kumar, ICAR-Central Institute of Fisheries Education, Mumbai, India
Dr. R. Valarmathi, ICAR-Sugarcane Breeding Institute, Coimbatore, India
Dr. Rajkumar, ICAR-Central Plantation Crops Research Institute, Kasaragod, India
Dr. Ramesh Kumar, ICAR-Indian Institute of Maize Research, Ludhiana, India
Dr. Rashmi Mahalle, Chungnam National University, Daejeon, South Korea
Dr. S. Satpathy, ICAR-Central Research Institute for Jute and Allied Fibres, Barrackpore, India
Dr. Samart K., M. S. Ramaiah Institute of Technology, Bangalore, India
Dr. Shravan M. Haldhar, ICAR-Central Institute for Arid Horticulture, Bikaner, India
Dr. Subhendu Jash, Bidhan Chandra Krishi Viswavidyalaya, Jhargram, India
Dr. T. Krishnakumar, ICAR-Central Tuber Crops Research Institute, Thiruvananthapuram, India
Dr. Teekam Singh, ICAR-Indian Agricultural Research Institute, New Delhi, India
Dr. Tulsi Saran Ghimiray, Uttar Banga Krishi Viswavidyalaya, Cooch Behar, India
Dr. Ujjwal Layek, Rampurhat College, Birbhum, India
Dr. Vikas Kumar, ICAR-Central Inland Fisheries Research Institute (ICAR-CIFRI), Barrackpore, India
Dr. Vikas Ramteke, Shaheed Gundadhoor College of Agriculture & Res. Station, Kumarawand, India
Dr. Zothansiama, Mizoram University, Aizawl, India
u Indian Subscribers should send subscription in INR by direct transfer to our bank account in India or by DD /Cheque only.
No cash transaction is accepted.
v Overseas Subscribers should send subscriptions in US Dollars only by Direct Transfer.
SUBSCRIPTION INFORMATION
Region Institutional Individual Industry Research Scholar Life subscriber
v Bank charges including those of remitting and / or intermediary bank(s) are to be borne by the remitter.
Compliance Requested v Obtain SWIFT copy (other countries) / NEFT or UTR Number (India) from remitting / transferring Bank after
making payment and send it’s scan copy by E-mail to: editor@jeb.co.in with filled-in Order Form
Name: ..........................................................................................................................................................................................................................................................................
Address: ...................................................................................................................................................................................................................................................................
..........................................................................................................................................................................................................................................................................................
p-ISSN: 0254-8704 l e-ISSN: 2394-0379 l CODEN: JEBIDP Journal website : www.jeb.co.in « E-mail : editor@jeb.co.in « ( +94-522-4017359
®
Journal of Environmental Biology
p-ISSN: 0254-8704 • e-ISSN: 2394-0379 • CODEN: JEBIDP JEB
(Full length papers are available on our website: www.jeb.co.in)
CONTENTS
Volume 45, Number 5, September 2024
WOS - Impact Factor : 0.6 Scopus Impact Factor : 0.703 WOS - JCI : 0.12 NAAS : 6.70 SJR : 0.23 H Index : 61
REVIEW ARTICLE
487-497 Cassava breeding: Classical to recent breeding approaches for food, industry and climate resilience
M. Velmurugan, R. Janaharshini, C. Indu Rani, S.R. Venkatachalam and P.A. Saravanan
Medical Microbiology
507-514 Biofilm mediated antibiotic resistant oral bacteria among Parkinson's patients
J. Joel, P. Xavier, J.S. Pillai, T.S. Sujitha, A. Iyer, S. Sree and S. Murugan
Environmental Pollution
515-524 Microplastic pollution in the surface water of Yele Mallappa Shetty Lake, Bengaluru: first report
N.S. Kaviyarasi, V. Prasanna, S. Abitha and A.T. Anifowoshe
Animal Physiology
525-533 Ameliorative extract Syzygium cumini seed extract on lipid peroxidation and antioxidant activity
in alloxan induced diabetic Wistar albino rats
E. Kavitha and M. Sendhilvadivu
Shellfish Immunology
534-541 Short-term dietary supplementation of β-glucan and chitosan modulates the immune response
in freshwater prawn, Macrobrachium rosenbergii (De Man, 1879)
S. Sahoo, M.R. Badhe, A. Paul, P.K. Sahoo, K.C. Das, D. Panda, B.R. Pillai, S. Baliarsingh,
B.B. Patnaik and J. Mohanty
551-557 Influence of different stocking densities of pearlspot (Etroplus suratensis) on plankton diversity
indices of biofilm-based rearing system
S.R. Yadav, B.R. Chavan, N.K. Chadha, P.S. Bodake, K.K. Krishnani, P.B. Sawant and R. Bhosle
565-575 Phyto-sociological changes in the Goima Forest, Gujarat due to human disturbances and
their implications for conservation
S.S. Malek, M.H. Patel, K.R. Rathod, S.K. Jha, B.S. Desai and M.B. Tandel
Ecosystem Valuation
576-585 Economic valuation of cultural ecosystem services: A case of tropical reservoir ecosystem
M. Meharoof, V.K. Yadav, A. Sharma, V. Anitha, T.T. Paul, L. Paul and C. P. Dave
595-602 Accelerated development of maize inbred lines suitable for high density through doubled haploid
technology
H. Kaur, S. Sandhu, G. Singh, F. Khan, U.P. Praba and G. Kaur
Entomology
603-611 Effect of biotic and abiotic factors on the population dynamics of Nilaparvata lugens in the
middle Gangetic Plains of India
K.R. Sharma, S.V.S. Raju, S.K. Singh, R. Singh, U. Chandra, P.K. Dalal and R. Kumar
Namatology
612-618 Performance of tomato cultivars grafted on root-knot nematode resistant Solanum torvum
rootstock for growth and yield parameters
K. Sindhuja, S. Mallesh, P. Holajjer, G. Jyothi and S. Praneeth
619-625 Screening of newly isolated indigenous entomopathogenic nematodes against Spodoptera litura
Fabricius (Lepidoptera: Noctuidae)
R. Pervez, D. Sagar and Rajkumar
Agrometeorology
626-634 Evaluating influence of weather on Ascochyta blight severity in chickpea using correlation
network, regression and principal component analysis
B. Biswas, S. Kashyap, C. Kaur and R.S. Bal
Horticulture
635-644 Nutrient responsiveness and correlation analysis of cashew (Anacardium occidentale L.) cv.
Balabhadra for vegetative, reproductive traits and nut yield under coastal Odisha condition
C. Jena, P.K. Panda, K. Sethi, R.K. Nayak and R.K. Panda
Abstract
Aim: The aim of this study was to examine the oral microbe biofilm and antibiotic resistance in individuals with Parkinson's disease compared to those
without the condition.
Methodology: In this study, the oral bacteria of older patients with Parkinson's disease and those without the condition were examined for antibiotic
resistance and biofilm formation. In this study, the microbiologists examined oral samples collected from 33 individual, out of which 18 sufferred from
Parkinson's disease while the remaining 15 individuals were normal. This case involved the use of the Matrix-Assisted Laser Desorption/Ionization-Time
of Flight (MALDI-TOF) technology to identify six different species.
Results: The analysis of oral samples showed the presence of six isolates viz. Staphylococcus epidermis, S. auricularis, S. simiae, Panebacillus
thiaminolyticus, P. aeruginosa and Bacillus cereus. Out of these, P. thiaminolyticus was absent in the control group. The incidence of oral microorganisms
was somewhat higher in Parkinson's disease patients than control individuals, however, there was no discernible variation in the oral bacterial strains
found in the two research groups. The isolates underwent further analysis following Congo Red Agar and Tissue Culture Plate methods and showed
positive result for biofilm formation. Each isolate found in the Parkinson's disease groups were found resistant to at least five antibiotics used.
Interpretation: The ability to produce biofilm was present in approximately 83.3% of the isolates from the Parkinson's disease group and 80% of those
from the control group. This study provides a deeper understanding of the relationship between biofilm-producing, antibiotic-resistant oral bacteria and
Parkinson's disease, and also address the need for effective management of oral hygiene in Parkinson’s patients.
Key words: Antibiotic resistance, Biofilm, Oral microbiota, Oral health, Parkinson’s disease
Development of
antibacterial Collection of oral samples
strategies from individuals Identification of six bacterial
in combating species from oral sample via
drug-resistant MALDI-TOF technology
bacteria for the
effective Staphylococcus epidermis, S. auricularis,
management of Testing of antibiotic S. simiae, Pseudomonas aeruginosa,
oral hygeine in resistance of isolates Bacillus cereus and
Parkinson's Panebacillus thiaminolyticus
patients
Comparison of bacterial species
between Parkinson disease and
Examination of isolates
Non-Parkinson disease groups
for biofilm development
How to cite: Joel, J., P. Xavier, J.S. Pillai, T.S. Sujitha, A. Iyer, S. Sree and S. Murugan: Biofilm mediated antibiotic resistant oral bacteria among Parkinson's patients. J.
Environ. Biol., 45, 507-514 (2024).
(Educational Services Set-up)
J. Joel et al.: Antibiotic resistant oral bacteria in Parkinson’s patients
Congo Red dye. The plates were incubated for 24 hr at 37 °C are more likely to suffer from Parkinson’s disease than women.
(Bose et al., 2009). The isolates producing biofilms showed black Additionally, it was reported that each patient suffering from
colonies whereas the non-biofilm producing isolates developed Parkinson's disease experienced resting tremors.
red colonies.
The proportion of Parkinson's disease cases presenting
Tissue culture plate method: An overnight culture in nutrient various symptoms within the study group was analyzed, revealing
broth and a 1:100 dilution in BHI broth were used for the biofilm tremor as the most prevalent symptom, affecting all individuals
development experiment in microtiter wells. Using a flat-bottom (100%). Additionally, difficulty in walking (66.67%) and excessive
96-well polystyrene microtiter plate, a 200µl of cell suspension salivation (38.89%) were also commonly reported, while memory
was added to each well. Following a 48 hrs incubation period at loss (27.78%) and depression (11.11%) were less frequently
35˚C, the detached cells underwent three gentle rinses with observed among the affected individuals. Salivary microbes from
sterile distilled water. Subsequently, the bacteria adhered to the Parkinson’s disease patients and healthy individuals were
surface were stained using crystal violet, recleaned and de- compared (Table 1) showing S. epidermidis to be present in
stained with ethanol-acetone (95:5, v/v). Optical density was read 16.67% of PD individuals compared to 13.34% in the control
at 570 nm wavelength (OD) 570nm using 200µl of the combined group. S. auricularis was found in 5.56% of Parkinson's patients,
solution that was transferred to a 96-well microtiter plate (Pierce significantly lower than the 20.0% observed in the control group.
et al., 2008). Micro-ELISA Auto-reader recorded the absorbance. Notably, P. thiaminolyticus was detected in 33.33% of individuals
Each test was run thrice, and the mean OD570 value of the wells with Parkinson's disease but was absent in the control group.
that were tested was used. Based on the ODs in the BHI broth, the
biofilm formation was separated into three categories: biofilm B. cereus was present in 11.11% of Parkinson's patients,
non-formers (OD570<0.2), biofilm formers of weak level (OD570 whereas it was more prevalent in the control group (33.34%).
in the range of 0.2-1.0), and biofilm formers of strong level Finally, P. aeruginosa was present in 22.22% of Parkinson's
(OD570 >1.0) (Bose et al., 2009). patients and 26.67% of controls. These variations suggest that
Parkinson's disease may influence the composition of the oral
Antibiotic sensitivity test: The bacteria screened for biofilm microbiota, potentially impacting oral health and the propensity
production were further analysed for antibiotic susceptibility test. for certain infections. Saliva samples from both group showed the
A sterile cotton swab was dipped into the overnight culture, presence of Staphylococcus species viz., S. epidermidis, S.
employing the subsequent drugs: Imipenem (10 mcg), Linezolid auricularis, and S. simiae, The prevalence of microorganisms
(30 mcg), Methicillin (5 mcg), Minocycline (30 mcg), Ampicillin (10 across the two groups did not differ significantly, with the
mcg), Piperacillin-Tazobactam (100/10 mcg), Tigecycline (15 exception of P. thiaminolyticus, which was absent in control
mcg), Cefepime (30 mcg), Cefotaxime (30 mcg), Ceftazidime (30 participants. P. thiaminolyticus predominated (33.33%) in the
mcg), Co- Trimoxazole (25 mcg) and Ceftriaxone (30mcg) (Hi- saliva of Parkinson’s disease patients, but B. cereus was found in
Media, Mumbai). The Mueller-Hinton agar medium (Hi-Media, higher percentage (33.34%) of all other isolates in the saliva of
Mumbai) was thoroughly streaked with swabs, and the antibiotic normal patients. The presence of P. aeruginosa was similar in
disc was gently placed above it with the help of tweezers. The both patients. The identified oral bacterial species were tested for
plates were incubated at 37 °C for 24 hr. The inhibition zones on the existence of biofilms by Congo red agar plate method. The
the plates were checked after the incubation period. The zones oral isolates showed dry, black colonies that suggested the
were measured and interpreted in accordance with the Clinical formation of biofilms, while red colonies revealed the presence of
and Laboratory Standard Institute's Guidelines (Javiya et al., non-biofilm producers (Table 2).
2008; CLSI, 2016).
From the tissue culture plate analysis, a high prevalence
Statistical analysis: All experiments were performed in triplicate of biofilm was observed among oral isolates obtained from
and the data were analyzed using a Student's t-test. Statistical individuals with Parkinson's disease, with 61.29% of samples
significance was determined at a p-value threshold of 0.05.
Results and Discussion Table 1: Microbiota profiles in the oral cavity of individuals with and
without Parkinson’s disease
In total thirty-three (N=33) participants including 15
Microorganisms Parkinson’s Control (%)
Parkinson’s disease patients and 15 normal individuals (and 3
disease (%)
excluded) participated in this study. Participants suffering from
Parkinson’s disease were 50 years old. The prevalence of S. epidermidis 3 (16.67) 2 (13.34)
Parkinson's disease increases with advancing age, with a notable S. auricularis 1 (5.56) 3 (20.0)
rise observed in individuals aged 60 to 64 (33.33%) and those S. simiae 2 (11.11) 1 (6.67)
aged 65 and above (50%), according to the distribution among P. thiaminolyticus 6 (33.33) 0
Parkinson’s disease patients in the specified age groups. It has B. cereus 2 (11.11) 5 (33.34)
been found that illness incidence advances with age and that men P. aeruginosa 4 (22.22) 4 (26.67)
Table 2: Prevalence of biofilm development among oral microflora in Parkinson’s disease and control populations
Parkinson’s disease Control
Microorganisms Biofilm Non-biofilm Biofilm Non-biofilm
Producing (%) Producing (%) Producing (%) Producing (%)
S. epidermidis 2 (66.67) 1 (33.33) 1 (50) 1 (50)
S. auricularis 1 (100) 0 2 (66.7) 1 (33.33)
S. simiae 1 (50) 1 (50) 1 (100) 0
P. thiaminolyticus 0 6 (100) - -
B. cereus 2 (100) 0 3 (60) 2 (40)
P. aeruginosa 3 (75) 1 (25) 4 (100) 0
Table 3: Biofilm-producing microorganism identification in Parkinson’s than women. Moisan et al. (2016) found that the male-to-female
disease and Non-Parkinson’s disease Individuals ratio for the disease increases with age, which is in line with the
results of the current investigation. Rozas et al. (2021),
Microorganisms Parkinson’s disease Non-Parkinson’s disease investigated the factors influencing the oral microbiota in
S. epidermidis + + individuals with Parkinson's disease. The findings revealed an
S. auricularis ++ ++ increased presence of opportunistic oral pathogens among the
S. simiae ++ + patients. The study identified specific factors, such as dysphagia
P. thiaminolyticus - -
and drooling (both with a significance level of p < 0.05), along with
salivary pH (p < 0.005), that had a significant impact on the beta-
B. cereus ++ +
diversity of soft tissues and composition of oral microbiota.
P. aeruginosa ++ ++
Previous research has demonstrated that non-oral species
Note: (+++) Strong, (++) Moderate, (+) Weak, (-) No biofilm production detected in the oral microbiota may function as a repository for
medically significant pathogens, rather than merely being the
result of contamination during sample collection (Botero et al.,
showing biofilm production. The optical density (OD) 2012; Souto and Colombo, 2008; Fritschi et al., 2008; Gonçalves
measurements of stained adherent bacteria was analyzed with a et al., 2009; Wang et al., 2023). However, it was observed that all
micro-ELISA auto reader operating at 570 nm. Based on OD the six isolates were sensitive to Imipenem and Piperacillin-
values, isolates were categorized as strong, moderate, weak, or tazobactam antibiotics.
non-biofilm producers. Staphylococcus species (S. epidermidis,
S. auricularis and S. simiae) and B. cereus showed varying Staphylococcus species such as S. auricularis, S.
degrees of biofilm production in both groups, with generally epidermidis and S. simiae have been found to inhabit the oral
higher levels observed in Parkinson's disease patients compared cavity, and under certain conditions, it can lead to localized or
to controls as shown in table 3. Notably, P. aeruginosa systemic infections (Kloos and Bannerman, 1994). For instance,
demonstrated significant biofilm production in both groups. S. auricularis, typically found in the ear, can cause infections if it
Notably, all oral isolates exhibited resistance to a minimum of five accesses sterile body sites; S. epidermidis, a common skin
antibiotics, as shown in Table 4. Table 5 presents the relationship commensal, can form biofilms on medical devices and contribute
between antibiotic resistance patterns and biofilm-forming oral to infections, particularly in immunocompromised individuals; and
microorganisms. Each microorganism displayed resistance to S. simiae, although less commonly discussed, can cause
multiple antibiotics, with B. cereus resistant to 7 antibiotics and P. infections if it enters the bloodstream or other sterile areas. The
aeruginosa resistant to 6 antibiotics, respectively (table 4). frequency of Staphylococcus species in oral samples, as
Staphylococcus species, including S. auricularis, S. epidermidis, reported by Simes-Silva et al. (2018) and Smith et al. (2011),
and S. simiae, exhibited resistance to five antibiotics each. This supports their common presence in the oral cavity. Their
suggests a concerning trend of multidrug resistance among persistence can be attributed to mechanisms such as biofilm
biofilm-forming oral microorganisms associated with Parkinson's formation, which protects them from host immune responses and
disease, emphasizing the need for effective antimicrobial antibiotics (Beatriz et al., 1999; Bose et al., 2009); adhesion to
strategies in managing oral health in patients. epithelial cells facilitated by surface proteins; and the
development of antibiotic resistance, particularly in species like S.
Approximately, 0.02% people above 65 years of age all epidermidis.
over the world suffer from Parkinson's disease caused by
substantia nigra of the brain where nerve cells slowly die off. Coagulase Negative Staphylococci (CoNS), especially S.
About 88.8% of the Parkinson’s disease patients in this research epidermidis, pose a significant threat due to their ability to develop
were males, while the remaining 11.2% were females. According antibiotic resistance and form biofilms. These bacteria can
to Moisan et al. (2016) and Roohani et al. (2013), men are more adhere to oral surfaces, contributing to periodontal disease and
likely to suffer from Parkinson's disease almost 1.6 times more complicating treatment due to their resistance to common
510 Journal of Environmental Biology, September 2024
J. Joel et al.: Antibiotic resistant oral bacteria in Parkinson’s patients
Table 4: Antimicrobial pattern for oral microorganisms isolated from Parkinson’s disease subjects
Antibiotics S. epidermidis S. auricularis S. simiae P. thiaminolyticus P. aeruginosa B. cereus
AMP R R R R R R
CAZ R R R R S R
MET R R R R R R
CTX R R R I I R
CPM R R R R S R
CTR I R R R S R
TGC S S S S R S
COT I I I I R R
LZ S S R S R S
MI S I I S R I
PIT S S S S S S
IPM S S S S S S
*AMP- Ampicillin; CAZ- Ceftazidime; MET- Methicillin; CTX- Cefotaxime; CPM- Cefepime; CTR- Ceftriaxone; COT- Co-Trimoxazole; TGC-
Tigecycline; LZ- Linezolid; MI- Minocycline; IMP- Imipenem; PIT- Piperacillin-tazobactam. **R- resistant; I- Intermediate; S- Sensitive
antibiotics like β-lactams, gentamicin and erythromycin (Asante Table 5: Relationship between the pattern of antibiotic resistance and the
et al., 2020). These mechanisms highlight the adaptability of biofilm-forming oral microorganisms
Staphylococci to the oral environment and their potential role in Microorganisms Parkinson’s disease
oral and systemic infections, underscoring the importance of
monitoring and understanding their behavior to manage and B. cereus AMP, CAZ, MET, CTX, CPM, CTR, COT (7)
P. aeruginosa AMP, MET, TGC, COT, LZ, MI (6)
prevent infections effectively. Therefore, due to the presence of
S. auricularis AMP, CAZ, MET, CTX, CPM, CTR (6)
CoNS in the oral cavity, Parkinson's patients may develop S. epidermidis AMP, CAZ, MET, CTX, CPM (5)
periodontal diseases (Manandhar et al., 2021). S. auricularis has S. simiae AMP, CAZ, MET, CTX, CPM (5)
hardly ever been found in oral infectious diseases (Braga et al.,
2005). Ouyang et al. (2024) reported the presence of P. *AMP- Ampicillin; CAZ- Ceftazidime; MET- Methicillin; CTX- Cefotaxime;
thiaminolyticus in an 80-year-old Parkinson's disease patient, CPM- Cefepime; CTR- Ceftriaxone; COT- Co-Trimoxazole; TGC-
Tigecycline; LZ- Linezolid; MI- Minocycline
which is in line with the present findings. This peculiar spore-
forming bacteria, like Paenibacillus sp. strain VT-400, which was
identified in the saliva of patients with acute lymphoblastic saliva includes proteins or glycoproteins that aid in the formation
leukaemia, has not been reported in humans (Tetz et al., 2015). P. of enamel layer, bacteria to cling to surfaces to form plaque (Holt
thiaminolyticus in oral samples of Parkinson's patients may be the et al., 1988; Zimmerman et al., 2013; Fiorillo, 2019; Hanisch et al.,
first of its kind. Furthermore, before Paenibacillus species were 2019). Microbes producing biofilms have caused numerous
identified as human pathogens, they were known to cause problems in agriculture, medicine and daily living (Shineman et
respiratory and urinary tract infections (Kim et al., 2010; Padhi et al., 2014). Germs that form biofilms are also assumed to be
al., 2013). resistant to antibiotics due in part to their slower rate of cell
proliferation when compared to free-living planktonic cells
Patients with periodontitis reported a notably higher (Chuard et al., 1993). P. aeruginosa and S. epidermidis were
prevalence of P. aeruginosa in their saliva and subgingival biofilm shown to be poor biofilm producers in the oral bacteria of
samples, according to Souto et al. (2014). The bacterium was Parkinson's patients, but B. cereus, S. auricularis, and S. simiae
found in both the participants in this study, indicating their role in were shown to be moderate biofilm builders (Hsueh et al., 2006;
the etiopathogenesis of periodontal diseases in Parkinson's Okajima et al., 2006). P. thiaminolyticus isolated from Parkinson’s
patients. Bakke et al. (2011) found that dental plaque, food disease was unique as it did not form biofilm. Santos et al. (2015)
particles, and periodontal health are more evident in patients with revealed the prevalence of Staphylococcus spp. in the
advanced Parkinson's disease (Hansen et al. 1993). Food debris subgingival biofilm. B. cereus in this study showed resistance to
may be the cause of B. cereus colonization in the oral cavity, most of the antibiotics tested, similar to report of Owusu-
which may be overlooked at early stages of pulmonary and Kwarteng et al. (2017). S. auricularis and P. aeruginosa both
systemic infections in immunocompromised individuals' showed resistance to Ampicillin, Methicillin, Tigecycline, Co-
development (El Saleeby et al., 2004). The salivary flow rate is Trimoxazole, Linezolid and Minocycline (Brown et al., 2012). The
essential for maintaining optimal oral health in Parkinson's presence of spores has significantly contributed to both the
patients because it plays a preventative function against plaque persistence of infections and the spread of antibiotic resistance.
and germs from mucosal and dental surfaces (Kennedy et al., Five different antibiotics were resistant to P. thiaminolyticus
1994; Müller et al., 2011). Previous studies have reported that (Barra-Carrasco et al., 2014). Furthermore, it was found that
among the Staphylococcus species isolated from oral samples, Authors’ contribution: J. Joel: Contributed to the research idea
S. auricularis was resistant to Ampicillin, Ceftazidime, Methicillin, and writing of the manuscript; P. Xavier: Contributed to the
Cefotaxime, Cefepime and Ceftriaxone, while S. epidermidis and research idea including framing of questionnaire for collecting
S. simiae were both resistant to Ampicillin, Ceftazidime, primary data; J.S. Pillai: Contributed to the research article
Methicillin, Cefotaxime and Cefepime. Conversely, all species of through writing; T.S. Sujitha: Contributed by writing the research
Staphylococcus were found to be susceptible to linezolid, article and conducting the research work; S. Sree: Collaborated
aligning with the findings of Abdel Halim et al. (2018). This in writing and editing the manuscript; A. Iyer: Assisted in writing
consistency underscores linezolid's effectiveness as a treatment and editing the manuscript; S. Murugan: Provided the initial
option against Staphylococcus infections, highlighting its research idea, assisted in coordination, and participated in the
potential as a reliable antibiotic in the face of rising antibiotic final correction of the paper.
resistance.
Funding: Not applicable.
The susceptibility of Staphylococcus species to linezolid
reinforces its role in clinical settings, particularly for infections that Research content: The research content of manuscript is
are resistant to other antibiotics. Most people agree that clinical original and has not been published elsewhere.
isolates with higher antibiotic resistance levels arise from repeated
medication exposure (Antoniadou et al., 2013). Cantas et al. (2013) Ethical approval: The researchers had maintained anonymity
suggest that there might be a connection between the environment with verbal consent from the patients under the meticulous
and the development of antibiotic resistance in microorganisms. In guidance of a medical expert, who also requested anonymity.
a similar study, Fleury et al. (2021), observed higher abundance of Since oral samples were collected through non-invasive
certain bacterial species, including Streptococcus mutans, procedures, no formal ethical approval was required. However,
Kingellaoralis, Actinomyces AFQC_s, Veillonella AFUJ_s, the study adhered to ethical standards, ensuring the utmost
Scardovia, Lactobacillaceae, Negativicutes, and Firmicutes were respect for the rights and privacy of the participants. The research
observed in patients. team remained committed to upholding ethical principles and
safeguarding the integrity of the study while contributing valuable
Conversely, there was a lower abundance of Treponema insights to the understanding of Parkinson's disease.
KE332528_s, Lachnospiraceae AM420052_s, and the phylum
SR1 in the same patient group (Fleury et al. 2021).The Conflict of interest: The authors declare that there is no conflict
heightened prevalence of multidrug-resistant CoNS among of interest.
Parkinson patients, as indicated by our research, is concerning.
Furthermore, this observation suggests a correlation with Data availability: Not applicable.
compromised dental hygiene and deteriorating oral health, likely
attributable to deficiencies stemming from Parkinson's disease, Consent to publish: All authors agree to publish the paper in
such as impaired motor control affecting oral care practices. Journal of Environmental Biology.
Beatriz, A., E. Gracia, M. Monzón, J. Leiva, C. Oteiza, M. Pérez, J.-L. aureus and other bacteria in untreated periodontitis. J. Dent. Res.,
Alabart, J.H. Yago, Antibiotic susceptibility assay for 87, 589–593 (2008).
Staphylococcus aureus in biofilms developed in-vitro, J. Giordano, A.: L. De Panfilis, M. Perin, L. Servidio, M. Cascioli, M.G.
Antimicrob. Chemother., 44, 43–55 (1999). Grasso, A. Lugaresi, E. Pucci, S. Veronese and A. Solari: Advance
Bose, S., M. Khodke, S. Basak and S.K. Mallick: Detection of biofilm Care Planning in neurodegenerative disorders: A scoping review.
producing Staphylococci: need of the hour. J. Clin. Diagn. Res., Int. J. Environ. Res. Public Hlth., 19, 803 (2022).
3,1915-1920 (2009). Gonçalves, A.J., J.A. Souza Jr., M.B. Menezes, N.K. Kavabata, A.B.
Botero, L. E., A.E.Toro, A.J. Patiño G. Salazar, J.C. Rodríguez, J.C. Suehara and C.N. Lehn: Pharyngocutaneous fistulae following
Suárez-Escudero G.A. Alarcón, A. Corcimaru, C. Osorio, J.S.Y. total laryngectomy comparison between manual and mechanical
Jeong and O. Alzate. Diabetes mellitus in patients with Alzheimer's sutures. Eur. Arch. Otorhinolaryngol., 266, 1793-1798 (2009).
disease: Clinical description and correlation with the APOE Hanaoka, A. and K. Kashihara: Increased frequencies of caries,
genotype in a sample population from the province of Antioquia, periodontal disease and tooth loss in patients with Parkinson's
Colombia. Biomedica, 11, 342 (2012). disease Clin. Neurosci, 16, 1279–1282 (2009).
Braga, C. A, S.B. da, C.M.F. Resende, A.C.N.R. Pestana, L.S. Carmo, Hanisch, M., T. Hoffmann, L. Bohner, L. Hanisch, K. Benz, J. Kleinheinz
J.E. Costa, L.A.F. Silva and M.A.R. Carvalho: Isolamento e and J. Jackowski. Rare diseases with periodontal manifestations.
identificação da microbiota periodontal de cães da raça Pastor Int. J. Environ. Res. Public Hlth., 16, 867 (2019).
Alemão. Cienc. Rural., 35, 385–390 (2005). Hansen, B. F., E. Bjertness and J.K. Gronnesby: A socio-ecologic model
Brandwein, M., D. Steinberg and S. Meshner: Microbial biofilms and the for periodontal diseases. J. Clin. Periodontol., 20, 531-535 (1993).
human skin microbiome. NPJ Biofilms Microbiomes, 2, 3 (2016). Holt, P.G., M.A. Schon-Hegrad and J. Oliver: MHC class II antigen-
Brown, A.N., K. Smith, T.A. Samuels, J. Lu, S.O. Obare and M.E. Scott: bearing dendritic cells in pulmonary tissues of the rat. Regulation
Nanoparticles functionalized with ampicillin destroy multiple- of antigen presentation activity by endogenous macrophage
antibiotic-resistant isolates of Pseudomonas aeruginosa and populations. J. Exp. Med., 167, 262–274 (1988).
Enterobacter aerogenes and methicillin-resistant Staphylococcus Hsueh, P.-R., Y.C. Liu, J. So, C.Y. Liu, P.C. Yang, K.T. Luh:
aureus. Appl. Env. Microbiol., 78, 2768–2774 (2012). Mycobacterium tuberculosis in Taiwan. J. Infect., 52, 77-85 (2006).
Byrne, S.J., D. Chang, G.G. Adams, C.A. Butler, E.C. Reynolds, I.B. Hsueh, Y.H., E.B. Somers, D. Lereclus and A.C. Wong: Biofilm formation
Darby and S.G. Dashper: Microbiome profiles of non-responding by Bacillus cereus is influenced by PlcR, a pleiotropic regulator.
and responding paired periodontitis sites within the same Appl. Env. Microbiol., 72, 5089–5092 (2006).
participants following non-surgical treatment. J. Oral Microbiol., Javiya, V.A., S.B. Ghatak, K.R. Patel, K.R. and J.A. Patel: Antibiotic
14, 2043595 (2022). susceptibility patterns of Pseudomonas aeruginosa at a tertiary
ŸCantas, L., S.Q.A. Shah, L.M.Cavaco, C.M. Manaia, F. Walsh, M. care hospital in Gujarat, India. Indian J. Pharmacol., 40, 230–234
Popowska, H. Garelick, H. Bürgmann and H. Sørum. A brief multi- (2008).
disciplinary review on antimicrobial resistance in medicine and its Jiménez, M. C. and F. J. G. Vingerhoets: Tremor revisited: Treatment of
linkage to the global environmental microbiota. Front. Microbiol., 4, PD tremor. Parkinson. Relat. Disord., 18, S93–S95 (2012).
96 (2013). Kamer, A.R., R.G. Craig, R. Niederman, J. Fortea and M.J. de Leon:
Chuard, C., P. Vaudaux, F.A. Waldvogel and D.P. Lew: Susceptibility of Periodontal disease as a possible cause for Alzheimer's disease.
Staphylococcus aureus growing on fibronectin-coated surfaces to Periodontology, 83, 242–271 (2020).
bactericidal antibiotics. Antimicrob. Age. Chemo., 37, 625–632 Kennedy, T. E., T. Serafini, J.R. de la Torre and M. Tessier-Lavigne:
(1993). Netrins are diffusible chemotropic factors for commissural axons in
Clinical and Laboratory Standards Institute (CLSI): Performance the embryonic spinal cord. Cell, 78, 425-435 (1994).
Standards for Antimicrobial Susceptibility Testing: Approved Kim, K. H., K.W. Kang, D.I. Kim, H.J. Kim, H.M. Yoon, J.M. Lee, J.C.
Standard M100-S26. 26th Edn., PA. Wayne (2016). Jeong, M.S. Lee, H.J. Jung and S.M Choi: Effects of acupuncture
Debowes, S., S. Tolle and A. Bruhn: Parkinson’s disease: considerations on hot flashes in perimenopausal and postmenopausal women--a
for dental hygienists. Int. J. Dent. Hyg., 11, 15–21 (2013). multicenter randomized clinical trial. Menopause, 17, 269–280
Einarsdóttir, E. R., H. Gunnsteinsdóttir, M.H. Hallsdóttir, S. Sveinsson, (2010).
S.R. Jónsdóttir, V.G. Olafsson,T.H. Bragason, S.R. Saemundsson Kloos, W.E. and T.L. Bannerman. Update on clinical significance of
and W.P. Holbrook: Dental health of patients with Parkinson's coagulase-negative Staphylococci. Clin. Microbiol. Rev., 7, 117–
disease in Iceland. Special care in dentistry. J. Dent., 29, 123–127 140 (1994).
(2009). Kumar, P. S.: From focal sepsis to periodontal medicine: a century of
El Saleeby, C.M., S.C. Howard, R.T. Hayden and J.A. McCullers: exploring the role of the oral microbiome in systemic disease. The
Association between tea ingestion and invasive Bacillus cereus J. Physiol., 595, 465–476 (2017).
infection among children with cancer. Clin. Infect. Dis., 39, Lema Tomé, C.M., T. Tyson, N.L. Rey, S. Grathwohl, M. Britschgi and P.
1536–1539 (2004). Brundin: Inflammation and α-Synuclein's prion-like behavior in
Fansano, A., N.P. Visanj, A.E. Lan and R.F. Pfeiffer: Gastrointestinal Parkinson's Disease—Is there a link?. Mol Neurobiol., 47,
dysfunction in Parkinson’s disease. Lancet Neurol., 14, 625-639 561–574 (2013).
(2015). Manandhar, S., A. Singh, A. Varma, S. Pandey and N. Shrivastava:
Fiorillo: Oral Health: The first step to well-being. Medicina, 55, 676 Phenotypic and genotypic characterization of biofilm producing
(2019). clinical coagulase negative Staphylococci from Nepal and their
Fleury, V., R. Himsl, S. Joost, N. Nicastro, M. Bereau, I. Guessous and antibiotic susceptibility pattern. Ann. Clin. Microbiol., 20, 41
P.R. Burkhard: Geospatial analysis of individual-based (2021).
Parkinson's disease data supports a link with air pollution: A case- Moisan, F., S. Kab, F. Mohamed, M. Canonico, M. Le Guern, C. Quintin,
control study. Parkinso. Rela. Disor., 83, 41-48 (2021). L. Carcaillon, J. Nicolau, N. Duport, A. Singh-Manoux, M.
Fritschi, B.Z., A. Albert-Kiszely and G.R. Persson: Staphylococcus Boussac-Zarebska and A. Elbaz: Parkinson disease male-to-
female ratios increase with age: French nationwide study and Pekkonen, E. Haapaniemi, S. Kaakkola, J. Eerola-Rautio, M.
meta-analysis. J. Neurol. Neuros. Psych., 87, 952–957 (2016). Pohja, M. Kinnunen, K Murros and P. Auvinen: Gut microbiota are
Mu, J., K.R. Chaudhuri, C. Bielza, J. de Pedro-Cuesta, P. Larrañaga and related to Parkinson's disease and clinical phenotype. J. Mov.
P. Martinez-Martin: Parkinson's disease subtypes identified from Disord., 30, 350–358 (2015).
cluster analysis of motor and non-motor symptoms. Front. Aging. Schwarz, F., K. Bieling, E. Nuesry, A. Sculean and J. Becker: Clinical and
Neurosci., 9, 301 (2017). histological healing pattern of peri-implantitis lesions following
Müller, P., B. Guggenheim, T. Attin, E. Marlinghaus and P.R. Schmidlin: non-surgical treatment with an Er: YAG laser. Las. Surg. Med., 38,
Potential of shock waves to remove calculus and biofilm. Clin. Oral 663–671 (2006).
Inves., 15, 959–965 (2011). Shineman, D. W., J. Alam, M. Anderson, S.E. Black, A.J. Carman, J.L.
Nielsen, S.D., N.M. Pearson and K. Seidler: The link between the gut Cummings, P.A. Dacks, J.T. Dudley, D.E. Frail, A. Green, R.F.
microbiota and Parkinson's disease: A systematic mechanism Lane, D. Lappin, T. Simuni, R.G. Stefanacci, T. Sherer and H.M.
review with focus on α-synuclein transport. Brain Res., 1769, Fillit: Overcoming obstacles to repurposing for neurodegenerative
147609 (2021). disease. Ann. Clin. Transl. Neurol., 1, 512-518 (2014).
Okajima, Y., S. Kobayakawa, A. Tsuji and T. Tochikubo: Biofilm formation Simonet, C., J. Bestwick, M. Jitlal, S. Waters, A. Ben-Joseph, C.R.
by Staphylococcus epidermidis on intraocular lens material. Invest Marshall, R. Dobson, S. Marrium, J. Robson, B.M. Jacobs, D.
Ophthalmol. Vis. Sci., 47, 2971-2975 (2006). Belete, A.J. Lees, G. Giovannoni, J. Cuzick, A. Schrag and A.J.
Ouyang, Q., L. Xu, Y. Zhang, L. Huang, L. Li and M. Yu: Nonlinear Noyce: Assessment of risk factors and early presentations of
relationship between homocysteine and mild cognitive impairment Parkinson disease in primary care in a diverse UK population.
in early Parkinson's disease: A cross-sectional study. JAMA Neurol., 79, 359–369 (2022).
Neuropsychiatr. Dis. Treat., 20, 913–921 (2024). Simões-Silva, L., S. Ferreira, C. Santos-Araujo, M. Tabaio, M. Pestana, I.
Owusu-Kwarteng, J., A. Wuni, F. Akabanda, K. Tano-Debrah and L. Soares-Silva and B. Sampaio-Maia: Oral colonization of
Jespersen: Prevalence, virulence factor genes and antibiotic Staphylococcus species in a peritoneal dialysis population: A
resistance of Bacillus cereus sensu lato isolated from dairy farms possible reservoir for PD-related infections? Canad. J. Infect.
and traditional dairy products. BMC Microbiol., 17, 65 (2017). Diseas. Medi. Microbiol., 2018, 1–6 (2018).
Padhi, S. K., S.Tripathy, R. Sen, A.S. Mahapatra, S. Mohanty and N.K. Smith, S.J., C. Souchay and C.J.A. Moulin: Metamemory and
Maiti: Characterisation of heterotrophic nitrifying and aerobic prospective memory in Parkinson's disease. Neuropsychology,
denitrifying Klebsiella pneumoniae CF-S9 strain for 25, 734–740 (2011).
bioremediation of wastewater. Int. Biodeterior. Biodegrad., 78, 67- Souto, R., and A.P. Colombo: Detection of Helicobacter pylori by
73 (2013). polymerase chain reaction in the subgingival biofilm and saliva of
Petersen P.E.: The World Oral Health Report: continuous improvement non-dyspeptic periodontal patients. J. Periodontol., 79, 97–103
of oral health in the 21st century--the approach of the WHO Global (2008).
Oral Health Programme. Community Dent. Oral. Epidemiol., 31, Souto, R., C.M. Silva-Boghossian and A.P.V. Colombo: Prevalence of
3–23 (2003). Pseudomonas aeruginosa and Acinetobacter spp. in subgingival
Pierce, C.G., P.Uppuluri, A.R.Tristan, F.L. Wormley, E. Jr., Mowat, G. biofilm and saliva of subjects with chronic periodontal infection.
Ramage and J.L. Lopez-Ribot. A simple and reproducible 96-well Braz. J. Microbiol., 45, 495–501 (2014).
plate-based method for the formation of fungal biofilms and its Tetz, G. and V. Tetz: In vitro antimicrobial activity of a novel compound,
application to antifungal susceptibility testing. Nat. Protoc., 3, Mul-1867, against clinically important bacteria. Antimicrob. Resist.
1494-1500 (2008). Infect. Control, 4, 45 (2015).
Postuma, R.B., D. Berg, M. Stern, W. Poewe, C.W. Olanow, W. Oertel, J. Van Den Eeden, S.K., C.M. Tanner, A.L. Bernstein, R.D. Fross, A.
Obeso, K. Marek, I. Litvan, A.E. Lang, G. Halliday, C.G. Goetz, T. Leimpeter, D.A. Bloch and L.M. Nelson: Incidence of Parkinson's
Gasser, B. Dubois, P. Chan, B.R. Bloem, C.H. Adler and G. disease: variation by age, gender, and race/ethnicity. Am. J.
Deuschl: MDS clinical diagnostic criteria for Parkinson's disease. Epidemiol., 157, 1015–1022 (2003).
J. Mov. Disord., 30, 1591–1601 (2015). van Stiphout, M.A.E., J. Marinus, J.J. van Hilten, F. Lobbezoo and C. de
Rather, M.A., K. Gupta and M. Mandal: Microbial biofilm: formation, Baat: Oral health of Parkinson's disease patients: A case-control
architecture, antibiotic resistance, and control strategies. Braz. J. study. Parkinson's Dis., 18, 285 (2018).
Microbiol., 52, 1701–1718 (2021). Vanbellingen, T., B. Kersten, A. Van de Winckel and M. Bellion: A new
Roohani, N., R. Hurrell, R. Kelishadi and R. Schulin: Zinc and its bedside test of gestures in stroke: The apraxia screen of TULIA
importance for human health: An integrative review. J. Res. Med. (AST). J. Neurol. Neuros. Psychi., 82, 389-392 (2010).
Sci., 18, 144–157 (2013). Vestby, L. K., T. Grønseth, R. Simm and L.L. Nesse: Bacterial biofilm and
Rozas, N.S., G.D. Tribble, C.B. Jeter and C.B. Oral: Factors that impact its role in the pathogenesis of disease. J. Antibiot., 9, 59 (2020).
the oral microbiota in Parkinson's disease. Microorganisms, 9, Wang, S., Y. Zhao, A.P. Breslawec, T. Liang, Z. Deng, L.L. Kuperman and
1616 (2021). Q. Yu: Strategy to combat biofilms: a focus on biofilm dispersal
Santos, D., A.R. Esteves, D.F. Silva, C. Januário and S.M. Cardoso: The enzymes. NPJ Biofil. Microbio., 9, 63 (2023).
impact of mitochondrial fusion and fission modulation in sporadic Zimmerman, M.A.: Resiliency Theory: A Strengths-based approach to
Parkinson's disease. Mol. Neurobiol., 52, 573-586 (2015). research and practice for adolescent health. Hlth. Educ. Behav.,
Scheperjans, F., V. Aho, P.A. Pereira, K. Koskinen, L. Paulin, F. 40, 381-383 (2013).